Pharmaceutical ophthalmological liquid compositions containing propionic acid derivatives as a preservative

Details for Australian Patent Application No. 2010266539 (hide)

Owner Allergan, Inc.

Inventors Olejnik, Orest

Agent Davies Collison Cave

Pub. Number AU-A-2010266539

PCT Pub. Number WO2011/002698

Priority 61/221,578 30.06.09 US

Filing date 28 June 2010

Wipo publication date 6 January 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2011/002698 Priority application(s): WO2011/002698

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010266549-Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

2010266537-Trans4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phen yl]methyl] (2-methyl-2H-tetrazol-5-yl) amino]-2,3,4,5-tetrahydro-7,9-dimethyl1H-1-benzazepin-1-yl]methyl]-cyclohex anecarboxylic acid